{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:11:31Z","timestamp":1790964691366,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34567-2","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:47:49Z","timestamp":1767628069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thapsigargin enhanced chemotherapeutic sensitivity of irinotecan in the inflammation-induced colorectal cancer model in mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Sukanya","family":"Baruah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-5930","authenticated-orcid":false,"given":"Manuj Kumar","family":"Bharali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Akhtara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydeep Kumar","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabana Sargam","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehnaz Siddika","family":"Rasid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitali","family":"Baidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epham Mayum Mohd Samir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"11","key":"34567_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","volume":"21","author":"JS Brown","year":"2023","unstructured":"Brown, J. S. et al. Updating the definition of cancer. Mol. Cancer Res. 21 (11), 1142\u20131147. https:\/\/doi.org\/10.1158\/1541-7786.MCR-23-0411 (2023).","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"34567_CR2","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"MS Hossain","year":"2022","unstructured":"Hossain, M. S. et al. Colorectal cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers 14 (7), 1732. https:\/\/doi.org\/10.3390\/cancers14071732 (2022).","journal-title":"Cancers"},{"issue":"4","key":"34567_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar, A. et al. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J. Gastrointest. Surg. 15 (4), 495\u2013519. https:\/\/doi.org\/10.4240\/wjgs.v15.i4.495 (2023).","journal-title":"World J. Gastrointest. Surg."},{"issue":"11","key":"34567_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s40262-023-01279-7","volume":"62","author":"M de With","year":"2023","unstructured":"de With, M. et al. Irinotecan-induced toxicity: A Pharmacogenetic study beyond UGT1A1. Clin. Pharmacokinet. 62 (11), 1589\u20131597. https:\/\/doi.org\/10.1007\/s40262-023-01279-7 (2023).","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"34567_CR5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/ijms26031313","volume":"26","author":"M Puzzo","year":"2025","unstructured":"Puzzo, M. et al. Colorectal cancer: current and future therapeutic approaches and related technologies addressing multidrug strategies against multiple level resistance mechanisms. Int. J. Mol. Sci. 26 (3), 1313. https:\/\/doi.org\/10.3390\/ijms26031313 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"34567_CR6","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"R Bayat Mokhtari","year":"2017","unstructured":"Bayat Mokhtari, R. et al. Combination therapy in combating cancer. Oncotarget 8 (23), 38022\u201338043. https:\/\/doi.org\/10.18632\/oncotarget.16723 (2017).","journal-title":"Oncotarget"},{"issue":"2","key":"34567_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.15430\/JCP.2014.19.2.75","volume":"19","author":"RK Yadav","year":"2014","unstructured":"Yadav, R. K., Chae, S. W., Kim, H. R. & Chae, H. J. Endoplasmic reticulum stress and cancer. J. Cancer Prev. 19 (2), 75\u201388. https:\/\/doi.org\/10.15430\/JCP.2014.19.2.75 (2014).","journal-title":"J. Cancer Prev."},{"issue":"1","key":"34567_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms22010004","volume":"22","author":"A Jaskulska","year":"2020","unstructured":"Jaskulska, A., Janecka, A. E. & Gach-Janczak, K. Thapsigargin\u2014from traditional medicine to anticancer drug. Int. J. Mol. Sci. 22 (1), 4. https:\/\/doi.org\/10.3390\/ijms22010004 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"34567_CR9","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/s41598-021-86551-1","volume":"11","author":"S Boinapally","year":"2021","unstructured":"Boinapally, S. et al. A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile. Sci. Rep. 11 (1), 7114. https:\/\/doi.org\/10.1038\/s41598-021-86551-1 (2021).","journal-title":"Sci. Rep."},{"key":"34567_CR10","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.2147\/DDDT.S209947","volume":"13","author":"L Wu","year":"2019","unstructured":"Wu, L. et al. Thapsigargin induces apoptosis in adrenocortical carcinoma by activating Endoplasmic reticulum stress and the JNK signaling pathway: an in vitro and in vivo study. Drug. Des. Devel. Ther. 13, 2787\u20132798. https:\/\/doi.org\/10.2147\/DDDT.S209947 (2019).","journal-title":"Drug. Des. Devel. Ther."},{"issue":"3","key":"34567_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ccr.2011.08.014","volume":"20","author":"T De Raedt","year":"2011","unstructured":"De Raedt, T. et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 20 (3), 400\u2013413. https:\/\/doi.org\/10.1016\/j.ccr.2011.08.014 (2011).","journal-title":"Cancer Cell."},{"key":"34567_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12964-019-0499-z","volume":"18","author":"P Lindner","year":"2020","unstructured":"Lindner, P. et al. Cell death induced by the ER stressor Thapsigargin involves death receptor 5, a non-autophagic function of MAP1LC3B, and distinct contributions from unfolded protein response components. Cell. Communication Signal. 18, 12. https:\/\/doi.org\/10.1186\/s12964-019-0499-z (2020).","journal-title":"Cell. Communication Signal."},{"key":"34567_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mrfmmm.2013.02.002","volume":"741\u2013742","author":"E Rudolf","year":"2013","unstructured":"Rudolf, E., Kralova, V., Rudolf, K. & John, S. The role of p38 in irinotecan-induced DNA damage and apoptosis of colon cancer cells. Mutat. Research\/Fundamental Mol. Mech. Mutagen. 741\u2013742, 27\u201334. https:\/\/doi.org\/10.1016\/j.mrfmmm.2013.02.002 (2013).","journal-title":"Mutat. Research\/Fundamental Mol. Mech. Mutagen."},{"issue":"4","key":"34567_CR14","doi-asserted-by":"publisher","first-page":"946","DOI":"10.20517\/cdr.2021.82","volume":"4","author":"S Ozawa","year":"2021","unstructured":"Ozawa, S., Miura, T., Terashima, J. & Habano, W. Cellular Irinotecan resistance in colorectal cancer and overcoming Irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a review. Cancer Drug Resist. (Alhambra Calif). 4 (4), 946\u2013964. https:\/\/doi.org\/10.20517\/cdr.2021.82 (2021).","journal-title":"Cancer Drug Resist. (Alhambra Calif)"},{"issue":"20","key":"34567_CR15","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3390\/cancers16203491","volume":"16","author":"S Saurav","year":"2024","unstructured":"Saurav, S. et al. Overcoming Irinotecan resistance by targeting its downstream signaling pathways in colon cancer. Cancers 16 (20), 3491. https:\/\/doi.org\/10.3390\/cancers16203491 (2024).","journal-title":"Cancers"},{"issue":"48","key":"34567_CR16","doi-asserted-by":"publisher","first-page":"19656","DOI":"10.1074\/jbc.M117.796920","volume":"292","author":"P Sehgal","year":"2017","unstructured":"Sehgal, P. et al. Inhibition of the sarco\/endoplasmic reticulum (ER) Ca2+-ATPase by Thapsigargin analogs induces cell death via ER Ca2\u2009+\u2009depletion and the unfolded protein response. J. Biol. Chem. 292 (48), 19656\u201319673. https:\/\/doi.org\/10.1074\/jbc.M117.796920 (2017).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"34567_CR17","doi-asserted-by":"publisher","first-page":"9301","DOI":"10.1038\/s41598-023-36555-w","volume":"13","author":"A Garg","year":"2023","unstructured":"Garg, A. et al. SelSA-1, a novel HDAC inhibitor demonstrates enhanced chemotherapeutic potential by redox modulation. Sci. Rep. 13 (1), 9301. https:\/\/doi.org\/10.1038\/s41598-023-36555-w (2023).","journal-title":"Sci. Rep."},{"key":"34567_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43046-021-00074-4","volume":"33","author":"G Borah","year":"2021","unstructured":"Borah, G. & Bharali, M. K. Green tea catechins in combination with Irinotecan attenuates tumorigenesis and treatment-associated toxicity in an inflammation-associated colon cancer mice model. J. Egypt. Natl Cancer Inst. 33, 17. https:\/\/doi.org\/10.1186\/s43046-021-00074-4 (2021).","journal-title":"J. Egypt. Natl Cancer Inst."},{"issue":"11","key":"34567_CR19","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.3390\/ijms24119544","volume":"24","author":"A Radajewska","year":"2023","unstructured":"Radajewska, A. et al. Combination of Irinotecan and melatonin with the natural compounds Wogonin and Celastrol for colon cancer treatment. Int. J. Mol. Sci. 24 (11), 9544. https:\/\/doi.org\/10.3390\/ijms24119544 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"34567_CR20","doi-asserted-by":"publisher","first-page":"797605","DOI":"10.3389\/fphar.2021.797605","volume":"12","author":"M Wang","year":"2021","unstructured":"Wang, M. et al. Amelioration of AOM\/DSS-induced murine colitis-associated cancer by Evodiamine intervention is primarily associated with gut microbiota-metabolism-inflammatory signaling axis. Front. Pharmacol. 12, 797605. https:\/\/doi.org\/10.3389\/fphar.2021.797605 (2021).","journal-title":"Front. Pharmacol."},{"issue":"9","key":"34567_CR21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00432-014-1899-5","volume":"141","author":"H Fujiki","year":"2015","unstructured":"Fujiki, H., Sueoka, E., Watanabe, T. & Suganuma, M. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds. J. Cancer Res. Clin. Oncol. 141 (9), 1511\u20131522. https:\/\/doi.org\/10.1007\/s00432-014-1899-5 (2015).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"50","key":"34567_CR22","doi-asserted-by":"publisher","first-page":"e13752","DOI":"10.1097\/MD.0000000000013752","volume":"97","author":"H Zhou","year":"2018","unstructured":"Zhou, H. et al. The prognostic value of proliferating cell nuclear antigen expression in colorectal cancer: A meta-analysis. Medicine 97 (50), e13752. https:\/\/doi.org\/10.1097\/MD.0000000000013752 (2018).","journal-title":"Medicine"},{"issue":"3","key":"34567_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/cancers15030902","volume":"15","author":"S Sharma","year":"2023","unstructured":"Sharma, S., Cwiklinski, K., Mahajan, S. D., Schwartz, S. A. & Aalinkeel, R. Combination modality using Quercetin to enhance the efficacy of docetaxel in prostate cancer cells. Cancers 15 (3), 902. https:\/\/doi.org\/10.3390\/cancers15030902 (2023).","journal-title":"Cancers"},{"issue":"Issue 12","key":"34567_CR24","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.jtho.2016.07.021","volume":"11","author":"Y Kim","year":"2016","unstructured":"Kim, Y. et al. Overexpression of \u00ce\u00b2-Catenin and Cyclin D1 is associated with poor overall survival in patients with stage IA\u00e2\u20acIIA squamous cell lung cancer irrespective of adjuvant chemotherapy. J. Thorac. Oncol. 11 (Issue 12), 2193\u20132201. https:\/\/doi.org\/10.1016\/j.jtho.2016.07.021 (2016). ISSN 1556\u2009\u2013\u20090864.","journal-title":"J. Thorac. Oncol."},{"issue":"14","key":"34567_CR25","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1091\/mbc.E11-04-0306","volume":"22","author":"MK Wendt","year":"2011","unstructured":"Wendt, M. K., Taylor, M. A., Schiemann, B. J. & Schiemann, W. P. Down-regulation of epithelial Cadherin is required to initiate metastatic outgrowth of breast cancer. Mol. Biol. Cell. 22 (14), 2423\u20132435. https:\/\/doi.org\/10.1091\/mbc.E11-04-0306 (2011).","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"34567_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.canlet.2015.03.025","volume":"362","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 Inhibition and surviving downregulation. Cancer Lett. 362 (1), 83\u201396. https:\/\/doi.org\/10.1016\/j.canlet.2015.03.025 (2015).","journal-title":"Cancer Lett."},{"issue":"11","key":"34567_CR27","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1349-7006.2003.tb01386.x","volume":"94","author":"T Tanaka","year":"2003","unstructured":"Tanaka, T. et al. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94 (11), 965\u2013973. https:\/\/doi.org\/10.1111\/j.1349-7006.2003.tb01386.x (2003).","journal-title":"Cancer Sci."},{"key":"34567_CR28","doi-asserted-by":"publisher","first-page":"35196","DOI":"10.1038\/srep35196","volume":"6","author":"Z Ma","year":"2016","unstructured":"Ma, Z. et al. Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. Sci. Rep. 6, 35196. https:\/\/doi.org\/10.1038\/srep35196 (2016).","journal-title":"Sci. Rep."},{"issue":"4","key":"34567_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/nu14040726","volume":"14","author":"J Deng","year":"2022","unstructured":"Deng, J. et al. Pre-administration of Berberine exerts chemopreventive effects in AOM\/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota. Nutrients 14 (4), 726. https:\/\/doi.org\/10.3390\/nu14040726 (2022).","journal-title":"Nutrients"},{"key":"34567_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12575-010-9032-x","volume":"12","author":"JN McGinley","year":"2010","unstructured":"McGinley, J. N., Thompson, M. D. & Thompson, H. J. A method for serial tissue processing and parallel analysis of aberrant crypt morphology, mucin depletion, and beta-catenin staining in an experimental model of colon carcinogenesis. Biol. Procedures Online. 12, 118. https:\/\/doi.org\/10.1007\/s12575-010-9032-x (2010).","journal-title":"Biol. Procedures Online"},{"issue":"1","key":"34567_CR31","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41467-019-11662-3","volume":"10","author":"Y Fang","year":"2019","unstructured":"Fang, Y. et al. CD36 inhibits \u03b2-catenin\/c-myc-mediated Glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat. Commun. 10 (1), 3981. https:\/\/doi.org\/10.1038\/s41467-019-11662-3 (2019).","journal-title":"Nat. Commun."},{"key":"34567_CR32","doi-asserted-by":"publisher","first-page":"103035","DOI":"10.1016\/j.redox.2024.103035","volume":"70","author":"M Shen","year":"2024","unstructured":"Shen, M. et al. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT. Redox Biol. 70, 103035. https:\/\/doi.org\/10.1016\/j.redox.2024.103035 (2024).","journal-title":"Redox Biol."},{"issue":"1","key":"34567_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12951-025-03143-1","volume":"23","author":"C Wu","year":"2025","unstructured":"Wu, C. et al. Trypsin-instructed bioactive peptide nanodrugs with cascading transformations to improve chemotherapy against colon cancer. J. Nanobiotechnol. 23 (1), 66. https:\/\/doi.org\/10.1186\/s12951-025-03143-1 (2025).","journal-title":"J. Nanobiotechnol."},{"key":"34567_CR34","doi-asserted-by":"publisher","unstructured":"Larissa Lipskaia, Z. et al. Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 1843 (11), 2705\u20132718. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.08.002 (2014).","DOI":"10.1016\/j.bbamcr.2014.08.002"},{"key":"34567_CR35","doi-asserted-by":"publisher","first-page":"1345516","DOI":"10.3389\/fphar.2024.1345516","volume":"15","author":"BS Alotaibi","year":"2024","unstructured":"Alotaibi, B. S., Selim, A. T., Makhlof, H. M. M. M. M. & M. E., & F., M. M New insights into the anticancer effects of polycladia crinita aqueous extract and its selenium nanoformulation against the solid Ehrlich carcinoma model in mice via VEGF, Notch 1, NF-\u043aB, Cyclin D1, and caspase 3 signaling pathway. Front. Pharmacol. 15, 1345516. https:\/\/doi.org\/10.3389\/fphar.2024.1345516 (2024).","journal-title":"Front. Pharmacol."},{"issue":"6","key":"34567_CR36","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4103\/1008-682X.157396","volume":"17","author":"K Wang","year":"2015","unstructured":"Wang, K. et al. Comparison of gene expression of the oncogenic Wnt\/\u03b2-catenin signaling pathway components in the mouse and human epididymis. Asian J. Androl. 17 (6), 1006\u20131011. https:\/\/doi.org\/10.4103\/1008-682X.157396 (2015).","journal-title":"Asian J. Androl."},{"key":"34567_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13578-022-00880-w","volume":"12","author":"W Song","year":"2022","unstructured":"Song, W. et al. E-cadherin maintains the undifferentiated state of mouse spermatogonial progenitor cells via \u03b2-catenin. Cell. Biosci. 12, 141. https:\/\/doi.org\/10.1186\/s13578-022-00880-w (2022).","journal-title":"Cell. Biosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34567-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34567-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34567-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:04:47Z","timestamp":1770109487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34567-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34567"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34567-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experiment was conducted and reported, strictly adhering to ARRIVE guidelines for reporting experiments on animals. All the procedures of experimentation involving animal study were approved by the Institutional Animal Ethical Committee (IAEC), Department of Zoology, Gauhati University, Assam, 781014, India (Ref: IAEC\/Per\/2024\/PP-IAEC\/2024-3\/8\/10).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"4551"}}